Filter
7157
Filtered Results: 7157
Text search:
World
Health
Organization,
et
al.
Featured
Recommendations
602
New Publications
1449
Language
Document type
No document type
3632
Studies & Reports
1572
Guidelines
971
Manuals
361
Strategic & Response Plan
208
Fact sheets
187
Training Material
131
Situation Updates
34
Resource Platforms
21
Infographics
16
Brochures
13
Online Courses
8
Videos
2
App
1
Countries / Regions
Global
325
India
168
Kenya
165
Latin America and the Carribbean
161
South Africa
154
Western and Central Europe
142
Ethiopia
119
Africa
112
Russia
107
Sierra Leone
104
Nigeria
100
Malawi
95
Uganda
86
Zambia
86
Nepal
85
Ukraine
85
Liberia
85
Syria
81
Tanzania
80
Bangladesh
80
Brazil
72
Myanmar / Burma
72
Eastern Europe
65
Ghana
63
Rwanda
57
Congo, Democratic Republic of
56
Middle East and North Africa
56
Mozambique
50
Senegal
49
South–East Asia Region
45
Philippines
42
Colombia
41
Germany
41
Asia
40
Burkina Faso
39
Guinea
39
Haiti
39
West and Central Africa
39
Yemen
36
Zimbabwe
35
Eastern Europe and Central Asia
35
Indonesia
34
Namibia
33
Venezuela
32
East and Southern Africa
31
South Sudan
29
Lesotho
27
Benin
27
Cameroon
27
Cambodia
27
Paraguay
24
Botswana
21
Argentina
20
Sudan
19
Angola
19
Pakistan
19
China
17
Mali
17
Peru
16
Chile
15
Lebanon
15
Somalia
15
Jordan
14
Western Pacific Region
14
Thailand
13
Guinea-Bissau
13
Tajikistan
12
Afghanistan
12
Côte d’Ivoire / Ivory Coast
12
Chad
12
Ecuador
12
Niger
11
USA
11
Vietnam
11
Sri Lanka
10
Central African Republic
10
Iraq
10
Madagascar
10
Eswatini/ Swaziland
10
Mexico
9
Albania
9
North America
9
Spain
9
Southern Africa
8
Bolivia
8
Kyrgyzstan
7
Saudi Arabia
7
Georgia
7
Libya
7
Laos
6
Egypt
6
Guatemala
6
Kazakhstan
5
Iran
5
Morocco
5
Tunisia
5
Belarus
5
Moldova
5
Palestine
5
Honduras
5
North Macedonia
4
Timor Leste/ East Timor
4
El Salvador
4
Turkey
4
Armenia
4
France
4
Portugal
4
Papua New Guinea
4
Togo
3
Canada
3
Congo-Brazzaville
3
Burundi
3
Qatar
3
Italy
3
Uruguay
3
United Kingdom
3
Israel
3
Nicaragua
3
Romania
3
Greece
3
Fiji
2
Estonia
2
Malaysia
2
Gabon
2
Turkmenistan
2
Jamaica
2
Japan
2
Denmark
2
Bosnia and Herzegovina
2
Djibouti
2
North Korea
1
Switzerland
1
Singapore
1
Mongolia
1
Bulgaria
1
Mauritania
1
Dominican Republic
1
Croatia
1
Hungary
1
Lithuania
1
Ireland
1
Belgium
1
Mauritius
1
Algeria
1
Morocco
1
Latvia
1
Slovakia
1
Poland
1
Bhutan
1
Cuba
1
Authors & Publishers
Publication Years
Category
Countries
2193
Clinical Guidelines
597
Public Health
410
Key Resources
390
Women & Child Health
381
Capacity Building
116
Pharmacy & Technologies
62
Toolboxes
COVID-19
741
Mental Health
707
HIV
636
TB
469
Planetary Health
368
NTDs
284
Disability
262
Caregiver
216
AMR
209
Rapid Response
173
Ebola & Marburg
162
NCDs
156
Conflict
138
Global Health Education
131
Refugee
117
Health Financing Toolbox
116
Pharmacy
93
Zika
65
Natural Hazards
64
Cholera
35
Specific Hazards
34
Polio
30
Social Ethics
26
Malaria
8
South Sudan
1
Typhoon
1
The Global guidance framework for the responsible use of the life sciences: mitigating biorisks and governing dual-use research (the framework) aims to provide values and principles, tools and mechanisms to support Member States and key stakeholders to mitigate and prevent biorisks and govern dual-u...
Q3: For behavioural and psychological symptoms in people with dementia, do following drugs, when compared to placebo/comparator, produce benefits/harm in the specified outcomes?
A resource for pesticide registrars and regulators.
The WHO urged governments to restrict access to highly toxic pesticides used for self-poisoning . Other effective interventions include education, youth intervention programs and follow-up of people at risk—and better data. Only 80 out of 183 WH...
Rabies is entirely preventable, and vaccines, medicines, tools and technologies have long been available to prevent people from dying of dog-mediated rabies. Nevertheless, rabies still kills about 60 000 people a year, of whom over 40% are children under 15, mainly in rural areas of economically dis...
Past quantitative research on health financing has focused mostly on the level and distribution of total expenditure, with little emphasis on the specific role of public funds, despite their known importance for universal health coverage (UHC). Health Accounts data do not disaggregate public expendi...
Module 5
Monitoring and Evaluation
October 2018
Module 5: Monitoring and evaluation. This module is for people responsible for monitoring PrEP programmes at the national and site levels. It provides information on how to monitor PrEP for safety and effectiveness, suggesting core and additiona...
Information note
Accessed November 2017.
The purpose of this field guide is to provide comprehensive information on planning and implementing high-quality3 SIAs for injectable vaccines and highlight the opportunities to strengthen RI and surveillance. The guide uses measles–rubella SIAs as the main example throughout, but the informatio...
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards
the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized ...
Meeting Report 27-29 October 2020
The overall goal of the meeting was to discuss recent changes in treatment regimens and diagnostics for drug-resistant TB and to determine how these impact on the definition of XDR-TB, with a view to revising this definition. The pre-existing definition of XDR-TB w...
In 2017, 3.6 million of the estimated 10 million people with TB worldwide were “missed” by national TB programmes (NTPs). Two thirds of them are thought to access TB treatment of questionable quality from public and private providers who are not engaged by the NTP. The quality of care provided i...
To complement the Global Strategy progress reporting, this report provides a detailed look at country leadership and action toward the Every Newborn National Milestones by 2020. Countries have taken the initiative to show the way forward and have demonstrated significant progress. As part of monitor...
Using the WHO model list of essential medicines to update a national essential medicines list
Since 1977, WHO has been working with countries to design the package of essential medicines as an integral component of treatment within the continuum of care, developing and disseminating the Model List ...
The purpose of this document is to offer guidance to Member States on quarantine measures for individuals in the context of COVID-19. It is intended for those responsible for establishing local or national policy for quarantine of individuals, and adherence to infection prevention and control measur...
Since the launch of the 2012–2020 World Health Organization (WHO) road map for the control, elim-ination and eradication of neglected tropical diseases (NTDs) (1), considerable progress against NTDs has been made. Between 2010 and 2020, the number of people requiring interventions against NTDs glo...
WHO has published the first-ever guidance on the clinical management of diphtheria. The only previously available guidance was an operational protocol. The new guidance followed the rigorous process for developing guidance at WHO.
It addresses the use of Diphtheria Antitoxin (DAT) in the treatmen...
